home / stock / rytm / rytm articles

RYTM Articles, Rhythm Pharmaceuticals Inc. - From 12/13/23

Stock Information
Company Name: Rhythm Pharmaceuticals Inc.
Stock Symbol: RYTM
Market: NASDAQ
Website: rhythmtx.com
Menu
RYTM RYTM Quote RYTM Short RYTM News RYTM Articles RYTM Message Board
Get RYTM Alerts

News, Short Squeeze, Breakout and More Instantly...
Rhythm Pharmaceuticals Sponsors Second Annual International Meeting on Pathway-Related Obesity: Vision & Evidence (IMPROVE) 2023 | Benzinga

-- More than 50 poster presentations highlighting new scientific developments to advance the care of people living with rare MC4R pathway diseases...
Rare Genetic Diseases Of Obesity-Focused Rhythm Pharma's Bardet-Biedl Syndrome Drug Meets Primary Goal In Pediatric Trial | Benzinga

During the R&D event for investors, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) released new topline data from its Phase 3 pediatrics t...

Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 | Benzinga

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a commercial-stage biopharmaceutical company focused on t...

Rhythm Pharmaceuticals Presents Data from its Long-term Extension Study of Setmelanotide Showing Sustained and Deepened BMI Reduction in Patients with Hypothalamic Obesity at One Year at ObesityWeek® 2023 | Benzinga

-- Patients with hypothalamic obesity (n=12) achieved mean BMI reduction of 25.5% at one year on setmelanotide treatment -- -- Three of 11 pediat...
Rhythm Pharmaceuticals Presents New Data at ESPE 2023 | Benzinga

BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a commercial-stage biopharmaceutical company focused on t...

Rhythm Pharmaceuticals Announces Update to September Conference Participation | Benzinga

BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a commercial-stage biopharmaceutical company focused on t...

Previous 10 Next 10